Drug intelligence / Profile preview

miRacle

Development stage
Preclinical
Lead developer
SirtLab
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Oral
01

Overview

miRacle is a preclinical-stage therapeutic candidate developed by SirtLab. It utilizes a dual anti-miRNA oligonucleotide approach designed to inhibit specific microRNAs (miRNAs) that naturally suppress the expression of Sirtuin 6 (SIRT6). By blocking these inhibitory miRNAs, miRacle aims to increase the activity and expression levels of SIRT6, a protein known for its critical roles in DNA repair, metabolic regulation, and longevity. The drug is being investigated for a broad range of indications, including cancer, cardiovascular diseases, metabolic disorders, and neurodegenerative diseases.

02

Targets

SIRT6 (Sirtuin 6)SIRT6-miRNAs (MicroRNAs targeting Sirtuin 6 mRNA)SIRT6-AS1 (Sirtuin 6 natural antisense transcript)

Beyond the preview

Go deeper on miRacle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miRacle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call